31 followers
🧵 1/16 Is 177Lu-PSMA-617 ready beyond mCRPC? Phase 3 changed advanced disease, but earlier settings rely on phase 2 data. Evidence + key limitations for clinical decisions. https://t.co/FIzN9Gx5mB #Medtwitter #Onctwitter #Oncology #Urology #NuclearMedi…